BROADCASTS.com

Vidcast:  https://youtu.be/huVl5qZPaOI

Two doses of the Novavax full length CoVid spike protein-nano particle vaccine induced significantly high and effective titers of IgG anti-CoVid antibody.  Novavax Inc. has just published these results on the pre-publication online server medrixiv.org.

A total of 1256 participants at 17 sites in the US and Australia completed the blinded, randomized study that tested 2 concentrations of the vaccine in 1 and 2 dose regimens.  The 2 doses employing 5 ug of vaccine triggered the highest levels of antibody with the lowest numbers of side effects.

This vaccine now moves on to Phase 3 testing before it can be presented to the FDA for an emergency use authorization.

https://www.medrxiv.org/content/10.1101/2021.02.26.21252482v1.full.pdf+html

#CoVid #novavax #vaccine #nanoparticle